Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Electroacupuncture for Preventing Adverse Events Associated With Cancer Immunotherapy: A Prospective, Multicenter, Open-Label, Single-Arm Clinical Study

NCT06891521 is registered in ClinicalTrials.gov with Qinghai Red Cross Hospital as lead sponsor.

NCT NCT06891521
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06891521 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Electroacupuncture for Preventing Adverse Events Associated With Cancer Immunotherapy: A Prospective, Multicenter, Open-Label, Single-Arm Clinical Study
Lead sponsor
Qinghai Red Cross Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 20, 2025
Completion date
June 1, 2028
Enrollment
123 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adverse events, cancer